Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06909851

Comparison of Pain Relief After Arthroscopic Knee Surgery: Adductor Canal Block and Genicular Nerve Block

This prospective randomized study aims to compare the analgesic efficacy of Adductor Canal Block (ACB) and Genicular Nerve Block (GNB) groups to relieve postoperative pain in participants between ages of 18-72 undergoing arthroscopic knee surgery under spinal anesthesia. The main question it aims to answer is:

To demonstrate whether Adductor Canal Block or Genicular Nerve Block is more effective in postoperative analgesia in patients undergoing arthroscopic knee surgery based on pain scores, opioid consumption and patient satisfaction.

Arthroscopic knee surgeries cause severe pain especially with movement in the post-operative period. After surgery, the movements of the participants are severely restricted because of pain, which increases the possibility of complications and postpones post-operative knee exercises. In this study, the participants' pain status, VAS score, opioid consumption and patient satisfaction will be measured with a simple scoring system for 24 hours at predetermined time points and then compared. Both types of blocks have pain-relieving effects. This study will only investigate which one is more effective in reducing pain, and there will be no deficiency in relieving the pain of the participants.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–72 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Başakşehir Çam & Sakura City Hospital

Istanbul, Turkey (Türkiye)

Location status: Recruiting

Location contact

ABDURRAHMAN ENGİN BAYDEMİR

SUB_INVESTIGATOR

FUNDA GÜMÜŞ ÖZCAN

SUB_INVESTIGATOR

MUZAFFER GENCER

CONTACT

[email protected]

+905059436459

MUZAFFER GENCER

PRINCIPAL_INVESTIGATOR

SİNAN ANAŞ

CONTACT

[email protected]

+905314220762

SİNAN ANAŞ

SUB_INVESTIGATOR

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Voluntary willingness to participate in the study.
  • Patients undergoing arthroscopic knee surgery (meniscus, ACL, arthroscopic intervention etc).
  • ASA I-II-III classification.
  • Aged between 18-72 years.
  • No contraindications for regional anesthesia, and deemed suitable for regional anesthesia by the anesthesiologist.
  • Undergoing surgery under spinal anesthesia.
  • Fully oriented and able to cooperate.

Exclusion criteria

  • Undergoing surgery under general anesthesia.
  • Chronic analgesic use.
  • Presence of an active infection at the procedure site.
  • Outside the appropriate age range.
  • Inability to comply with postoperative pain/NRS follow-ups.
  • ASA IV-V classification.
  • Non-voluntary patients.
  • Pregnancy.

Treatment and study plan

Adductor Canal Block (ACB)

Procedure

Evaluation of postoperative analgesic effectiveness of ACB block in participants undergoing arthroscopic knee surgery under spinal anesthesia.

Genicular Nerve Block (GNB)

Procedure

Evaluation of postoperative analgesic effectiveness of GNB block in participants undergoing arthroscopic knee surgery under spinal anesthesia.

Primary outcomes

  1. Effectiveness on Pain Scores (NRS)

    Time frame: Postoperative 24 hours

    Postoperative pain assessment is performed using the Numerical Rating Scale (NRS). Participants are asked about their rest pain at Baseline 0, postoperative 1st, 2nd, 4th, 6th, 12th, and 24th hours after applying a preoperative peripheral nerve block. With this method, participants rate their pain with a precise numerical value from 0 to 10. While zero(0) represents "no pain"; Ten (10) represents the opposite end of the pain continuum (e.g., "The most intense pain imaginable," "As intense pain as possible," "Maximum pain").

Secondary outcomes

  1. Amount of rescue analgesia administration

    Time frame: Postoperative 24 hours.

    After the surgery all patients will be given 4 times a day Paracetamol 1 gram. Patients who still have pain (NRS 4 or higher) will be given Tramadol 1 mg/kg (maximum 400 mg Tramadol daily). Postoperative 24 hours the amount of the rescue analgesic (Tramadol) will be noted.

  2. Postoperative Blood pressure

    Time frame: Postoperative 24 hours

    Participants' blood pressure (mm/hg) will be monitored for 24 hours (Post op 1st, 2nd, 4th, 6th, 12th and 24th hours) postoperatively.

  3. Length of hospital stay

    Time frame: Postoperative 14 days

    Length of hospital stay will be noted.

  4. First Time Of Mobilisation/Exercise

    Time frame: Postoperative 24 hours

    First time of mobilisation/exercise will be noted.

  5. The Time of Rescue Analgesic

    Time frame: Postoperative 24 hours

    After the surgery all patients will be given 4 times a day Paracetamol 1 gram. Patients who still have pain (NRS 4 or higher) will be given Tramadol 1 mg/kg (maximum 400 mg Tramadol daily). Postoperative 24 hours the time of the rescue analgesic usage (Tramadol) will be noted.

  6. Postoperative heart rate

    Time frame: Postoperative 24 hours

    Participants' heart rate (bpm) will be monitored for 24 hours (Post op 1st, 2nd, 4th, 6th, 12th and 24th hours) postoperatively.

  7. Postoperative oxygen saturation levels

    Time frame: Postoperative 24 hours

    Participants' oxygen saturation levels (spO2 %) will be monitored for 24 hours (Post op 1st, 2nd, 4th, 6th, 12th and 24th hours) postoperatively.

Study contacts

Contact information is provided by the study sponsor or research team.

MUZAFFER GENCER

CONTACT

[email protected]

+905059436459

SİNAN ANAŞ

CONTACT

[email protected]

+905314220762

Sponsors and collaborators

Lead sponsor

Başakşehir Çam & Sakura City Hospital

Other Gov

Registry information

Official study title

Comparison of the Effectiveness of Adductor Canal Block and Genicular Nerve Block on Postoperative Pain and Analgesic Use in Arthroscopic Knee Surgeries

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Apr 4, 2025
Registry last updated
Apr 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.